Andrew Mok
Stock Analyst at Barclays
(2.62)
# 2,063
Out of 5,241 analysts
297
Total ratings
55.12%
Success rate
-1.39%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVAH Aveanna Healthcare Holdings | Maintains: Overweight | $9.5 → $9 | $8.00 | +12.50% | 5 | May 18, 2026 | |
| ADUS Addus HomeCare | Maintains: Underweight | $102 → $92 | $92.19 | -0.21% | 7 | May 15, 2026 | |
| ASTH Astrana Health | Maintains: Equal-Weight | $26 → $37 | $39.67 | -6.73% | 3 | May 11, 2026 | |
| DVA DaVita | Maintains: Equal-Weight | $158 → $194 | $200.39 | -3.19% | 16 | May 8, 2026 | |
| OSCR Oscar Health | Maintains: Equal-Weight | $18 → $21 | $24.80 | -15.32% | 5 | May 7, 2026 | |
| CVS CVS Health | Maintains: Overweight | $93 → $101 | $95.74 | +5.49% | 13 | May 7, 2026 | |
| THC Tenet Healthcare | Maintains: Overweight | $257 → $238 | $196.57 | +21.08% | 18 | May 5, 2026 | |
| EHC Encompass Health | Maintains: Overweight | $153 → $140 | $107.93 | +29.71% | 20 | May 5, 2026 | |
| CI The Cigna Group | Maintains: Overweight | $303 → $310 | $288.01 | +7.64% | 12 | May 1, 2026 | |
| ALHC Alignment Healthcare | Maintains: Equal-Weight | $18 → $19 | $15.99 | +18.82% | 7 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $25 | $25.75 | -2.89% | 22 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $176 → $180 | $296.27 | -39.24% | 17 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $54 → $63 | $57.80 | +9.00% | 14 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $268 → $238 | $171.66 | +38.65% | 28 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $551 → $496 | $429.40 | +15.51% | 19 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $393 → $408 | $390.33 | +4.53% | 17 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $133 → $161 | $182.63 | -11.84% | 13 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $3.5 → $3 | $2.89 | +3.81% | 8 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $327 → $373 | $386.20 | -3.42% | 16 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $86 → $70 | $53.35 | +31.21% | 10 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $23 → $15 | $7.23 | +107.47% | 1 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $23 → $25 | $23.58 | +6.02% | 11 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $14 | $14.14 | -0.96% | 6 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $25 → $13 | $85.68 | -85.41% | 6 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $18 | $13.16 | +36.83% | 3 | Feb 3, 2026 |
Aveanna Healthcare Holdings
May 18, 2026
Maintains: Overweight
Price Target: $9.5 → $9
Current: $8.00
Upside: +12.50%
Addus HomeCare
May 15, 2026
Maintains: Underweight
Price Target: $102 → $92
Current: $92.19
Upside: -0.21%
Astrana Health
May 11, 2026
Maintains: Equal-Weight
Price Target: $26 → $37
Current: $39.67
Upside: -6.73%
DaVita
May 8, 2026
Maintains: Equal-Weight
Price Target: $158 → $194
Current: $200.39
Upside: -3.19%
Oscar Health
May 7, 2026
Maintains: Equal-Weight
Price Target: $18 → $21
Current: $24.80
Upside: -15.32%
CVS Health
May 7, 2026
Maintains: Overweight
Price Target: $93 → $101
Current: $95.74
Upside: +5.49%
Tenet Healthcare
May 5, 2026
Maintains: Overweight
Price Target: $257 → $238
Current: $196.57
Upside: +21.08%
Encompass Health
May 5, 2026
Maintains: Overweight
Price Target: $153 → $140
Current: $107.93
Upside: +29.71%
The Cigna Group
May 1, 2026
Maintains: Overweight
Price Target: $303 → $310
Current: $288.01
Upside: +7.64%
Alignment Healthcare
May 1, 2026
Maintains: Equal-Weight
Price Target: $18 → $19
Current: $15.99
Upside: +18.82%
May 1, 2026
Maintains: Equal-Weight
Price Target: $20 → $25
Current: $25.75
Upside: -2.89%
Apr 30, 2026
Maintains: Equal-Weight
Price Target: $176 → $180
Current: $296.27
Upside: -39.24%
Apr 29, 2026
Maintains: Overweight
Price Target: $54 → $63
Current: $57.80
Upside: +9.00%
Apr 28, 2026
Maintains: Overweight
Price Target: $268 → $238
Current: $171.66
Upside: +38.65%
Apr 27, 2026
Maintains: Overweight
Price Target: $551 → $496
Current: $429.40
Upside: +15.51%
Apr 24, 2026
Maintains: Overweight
Price Target: $393 → $408
Current: $390.33
Upside: +4.53%
Apr 24, 2026
Maintains: Underweight
Price Target: $133 → $161
Current: $182.63
Upside: -11.84%
Apr 23, 2026
Maintains: Equal-Weight
Price Target: $3.5 → $3
Current: $2.89
Upside: +3.81%
Apr 22, 2026
Maintains: Overweight
Price Target: $327 → $373
Current: $386.20
Upside: -3.42%
Apr 21, 2026
Maintains: Overweight
Price Target: $86 → $70
Current: $53.35
Upside: +31.21%
Apr 14, 2026
Maintains: Overweight
Price Target: $23 → $15
Current: $7.23
Upside: +107.47%
Mar 25, 2026
Maintains: Equal-Weight
Price Target: $23 → $25
Current: $23.58
Upside: +6.02%
Mar 3, 2026
Maintains: Equal-Weight
Price Target: $18 → $14
Current: $14.14
Upside: -0.96%
Feb 27, 2026
Maintains: Underweight
Price Target: $25 → $13
Current: $85.68
Upside: -85.41%
Feb 3, 2026
Maintains: Overweight
Price Target: $15 → $18
Current: $13.16
Upside: +36.83%